PIR International is pleased to announce the appointment of Luba Greenwood as Non-Executive Chair at Closed Loop Medicine.
Closed Loop Medicine is a TechBio company enhancing drug development through AI, machine learning, and personalized dosing, to bring forward the promise of precision care. The Company’s proprietary platform enhances treatment options by seamlessly integrating drugs and devices with patient-led digital experiences and closed-loop models of care – all under a single prescription. Working in combination with an expanding portfolio of new and established medicines, Closed Loop Medicine’s scalable approach to treating the individual, not just the disease, has the potential to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases.
Luba is a distinguished executive and investor with over 20 years’ experience in healthcare and tech. She has led over $10 billion USD in deals and investment over multiple therapeutic areas, leading success and scaling companies across the life sciences, medical devices, diagnostics, and tech sectors, including co-founding biotech and digital companies in the immunotherapy, women’s health, AI/ML and microbiome space. Leveraging broad corporate experience alongside legal and technical expertise, Luba’s appointment to Closed Loop Medicine’s Board will be instrumental in supporting development of the Company’s partnering and growth outside of the UK.
Luba Greenwood, Chair of the Board of Closed Loop Medicine, commented: “By catalyzing the development of more precise therapeutics across vast disease areas, Closed Loop’s platform has the potential to not only improve drug safety and efficacy, but transform the way healthcare is delivered. The work I do—and have been doing—has been driven by my dedication to bringing innovative products to market and ultimately to patients. I’m excited to be a part of the Company’s pioneering journey for better medicines, alongside a very impressive Board of Directors, to bring precision medicines to all patients in need.”
Dr Hakim Yadi PhD OBE, CEO & Co-Founder of Closed Loop Medicine, said: “On behalf of the entire team at Closed Loop, I am delighted to welcome Luba as Chair of our Board. Her impressive background and expertise in healthcare and tech, particularly as it pertains to the US market, will be instrumental in bolstering the Company’s strategic growth. With her strong track-record of building world-class teams and companies, we are well-positioned for the commercialization of our products and the expansion of our partnerships.”
Click here to read more: Closed Loop Medicine Appoints Luba Greenwood as Chair of the Board of Directors